|
|
|
||||||||||||
|
2.
Stratified epithelia are subdivided into the keratinizing, the non-keratinizing and
transitional type. The keratinizing and non-keratinizing epithelia have a basal cell layer
which invariably expresses cytokeratins 5 and 14. The suprabasal cell layers express
cytokeratins 4 and 13 in noncornifying epithelia and cytokeratins 1 and 10 in cornifying
epithelia. The transitional epithelium of the urinary bladder expresses cytokeratins 4 and
13 together with the cytokeratins of the simple epithelia i.e. cytokeratins 7,
8, 18, 19 and 20. 3.
Combined epithelia, morphologically characterized by a basal cell layer and a layer of
columnar cells both in contact with the basement membrane. The basal cells express
cytokeratins 5, 14 and 17, while the luminal cells can express different combinations of
cytokeratins 7, 8, 18 and 19. 4.
Squamous epithelia with a high cell turnover express cytokeratins 6 and 16. |
|
|
|
|
|
||
| Human uterine cervix after double-immunostaining with the cytokeratin 18 antibody RGE53 (A) which recognizes specifically glandular epithelium, and with a broad spectrum cytokeratin antiserum (B) staining both glandular and squamous epithelial cells. | ||
| In
the field of diagnostic medicine the antibodies against cytokeratins are instrumental in
the distinction of epithelial malignancies from sarcomas and lymphomas of various types.
Cytokeratin subtype expression patterns are however also being used to an increasing
extent in the distinction of different types of epithelial malignancies. The cytokeratin
antibodies are not only of assistance in the differential diagnosis of tumours using
immunohistochemistry on tissue sections, but are also a useful tool in cytopathology and
flow cytometric assays. |
||
|
|
||
|
RGE53
cytokeratin 18 staining of the glandular part of the human uterine cervix |
||
![]() RGE53 cytokeratin 18 staining of hepatocytes in human liver |
||
|
|
||
|
|
||
|
|
- Characterizations / References - Specific Applications |